About AIkido Pharma
AIkido Pharma is a company based in New York (United States) founded in 1967.. AIkido Pharma has completed 2 acquisitions, including CBM Biopharma and DatChat. AIkido Pharma offers products and services including AML and ALL Therapy, Pancreatic Cancer Therapy, Prostate Cancer Therapy, and Antiviral Platform.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aikido Labs Inc.
-
Annual Revenue
$9 K0as on Dec 31, 2019
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.46 M (USD), Post-IPO
Jul 01, 2015
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
CBM Biopharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AIkido Pharma
AIkido Pharma offers a comprehensive portfolio of products and services, including AML and ALL Therapy, Pancreatic Cancer Therapy, Prostate Cancer Therapy, and Antiviral Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapeutics targeting acute myeloid and lymphoblastic leukemia.
Treatment for pancreatic cancer based on preclinical results.
Therapeutic for prostate cancer with positive preclinical outcomes.
Broad-spectrum antiviral drugs licensed from universities.
Unlock access to complete
Advisor Team
4 people
Leadership Team
3 people
Chairman Team
1 people
Partner Team
1 people
Unlock access to complete
Funding Insights of AIkido Pharma
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $1.5M
-
First Round
First Round
(15 Nov 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2015 | Amount | Post-IPO - AIkido Pharma | Valuation |
investors |
|
| Apr, 2014 | Amount | Post-IPO - AIkido Pharma | Valuation |
investors |
|
| Nov, 2013 | Amount | Post-IPO - AIkido Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by AIkido Pharma
AIkido Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CBM Biopharma and DatChat. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapeutics for cancer treatment are developed.
|
2018 | ||||
|
Ephemeral messaging platform offered for enterprise social networking.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - AIkido Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aikido Pharma Comparisons
Competitors of AIkido Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aikido Pharma
Frequently Asked Questions about AIkido Pharma
When was AIkido Pharma founded?
AIkido Pharma was founded in 1967 and raised its 1st funding round 45 years after it was founded.
Where is AIkido Pharma located?
AIkido Pharma is headquartered in New York, United States. It is registered at New York, New York, United States.
Who is the current CEO of AIkido Pharma?
Anthony C. Hayes is the current CEO of AIkido Pharma.
What is the annual revenue of AIkido Pharma?
Annual revenue of AIkido Pharma is $9K as on Dec 31, 2019.
What does AIkido Pharma do?
AIkido Pharma was founded in 1967 in New York, United States, within the biotechnology sector. Therapeutics for cancer treatment are developed, with pipelines targeting pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The acute myeloid leukemia drug is formulated as a targeted therapy to address multiple resistance mechanisms. Operations are centered on advancing these oncology-focused drug candidates.
What products or services does AIkido Pharma offer?
AIkido Pharma offers AML and ALL Therapy, Pancreatic Cancer Therapy, Prostate Cancer Therapy, and Antiviral Platform.
How many acquisitions has AIkido Pharma made?
AIkido Pharma has made 2 acquisitions, including CBM Biopharma, and DatChat.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.